XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.87

+1.3%

Feb 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (8646)	2/7/1999 11:11:00 PM
From: Slugger	Read Replies (1) of 17367

<<Even in a strictly define Xoma's protocol is used for BPI and assuming that 25% deaths vs 15% with , then a physician will treat 75 out of 100 that did not needed BPI to survive, (less keep other benefits out of the calculations to make it easier for me to calculate), and despite compassionate care and hope the 15 deaths despite treatment will not "need" it since it will not help then anyway. In a strict protocol out of 100 patients, 90 will not need the drug, to benefit the other 10.>> :-) Now I understand! What you are saying is that in only 10 out of 100 cases the drug makes a difference (or 1 out of 100 in the case of Refludan).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next